← Open Payments lookup

STEVEN GUNDERSON: Open Payments

NPI 1790407286 · TALBOTT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,475 in 89 payments from 19 companies in 2025. Trend: 2023 $2,075 · 2024 $2,522 · 2025 $1,475

Food & beverage: $1,475
CompanyPaymentsAmount
Novo Nordisk Inc19$313
ABBVIE INC.18$219
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$209
AstraZeneca Pharmaceuticals LP10$199
Otsuka America Pharmaceutical, Inc.10$169
Axsome Therapeutics, Inc.3$66
E.R. Squibb & Sons, L.L.C.2$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34
GlaxoSmithKline, LLC.2$33
PFIZER INC.2$31

Products named: CAPLYTA, REXULTI, Ozempic, Rybelsus, FARXIGA, Wegovy, AIRSUPRA, UBRELVY.

Industry payments across TN — which companies pay providers there.